Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un an谩lisis del Riesgo Residual dependiente del perfil lip铆dico en el s铆ndrome coronario agudo
- 作者：Jesú ; s Millá ; n Nú ; ñ ; ez-Corté ; sa ; jesus.millan@madrid.org ; Juan Pedro-Botet Montoyab ; Xavier Pintó ; Salasc ; Antonio Herná ; ndez Mijaresd ; Vincent J. Careye ; Michel P. Hermansf ; Frank M. Sacksg ; Jean-Charles Frucharth
- 关键词：Riesgo residual ; Dislipemia ; Cardiopatí ; a isqué ; mica
- 刊名：Endocrinolog铆a y Nutrici贸n
- 出版年：2011
- 期刊代码：pca151_15750922
- 类别：med
- 出版时间：January 2011
- 卷：58
- 期：1
- 页码：38-47
- 文件大小：173 K
摘要
The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010.